BioSenic publishes new data on the mechanism of action of ar

INSIDE INFORMATION Combination of ATO with copper salts will allow BioSenic to work towards reducing the dosage of ATO in future trials overall and maintain efficacy Mont-Saint-Guibert,... | March 30, 2023

Related Keywords

Belgium , Paris , France General , France , Mont Saint Guibert , Waals Gewest , French , Belgian , Ghislaine Gasparetto , Neil Hunter Michelle Boxall , Carole Nicco , Francois Rieger , Bert Bouserie , Seitosei Actifin , Annie Florence Loyer , Ib Communications , International Media Enquiries , Euronext Brussels , Chronic Graft Versus Host Disease , Reactive Oxygen Species , Graft Versus Host Disease , Arthritis Rheum , Host Disease , Systemic Sclerosis , Louvain La Neuve Science Park , Mesenchymal Stromal Cells , Arsenic Trioxide , Systemic Lupus , Chief Executive , Belgian Media , Investor Enquiries , French Media Enquiries , French Investor Enquiries , Biosenic Sa Stock Exchange , News , Information , Press Release , Inside , Combination , F , To , Ith , Copper , Salts , Hill , Follow , Biosenic , O , Work , Cowards , Educing , The , Dosage , N , Future , Trials , Verall , End , Aintain , Fficacy Bios Be0974280126 ,